Presentations and Events

Patients Testimonials : The Impact Of EGFRi Induced Skin Toxicity

Lutris Pharma CEO Dr Noa Shelach on LUT014’s market potential & clinical progress

Improving Anti-Cancer Therapy By Reducing Dose Limiting Side Effects

Presented in H.C. Wainwright BIOCONNECT Virtual Conference, January 2022